Are you ready for the 11th ACCELERATE Annual Conference?
Join us to discuss, network, share knowledge and engage with our international, multi-stakeholder community on the latest in paediatric oncology drug development.
With your contribution, we will continue our mission to accelerate the implementation of new oncology drug development for children and adolescents in a changing global landscape.
More networking opportunities
Breakout sessions on emerging, hot topics are addressed in focused groups to define concrete actions stemming from the discussion. And what's more? Social events to get the full conference experience and engage with our international community of experts and patient advocates!
New venue in the center of Brussels!
Radisson Collection Grand Place Brussels is a fully refurbished hotel located in the city center, near the Grand Place, the main tourist attractions and shopping areas. Easy and fast access from Brussels National airport and Brussels train stations.
Book your hotel room with a reduced price today!
Hybrid event
We strongly believe in the power of multi-stakeholder networking, which is why we are looking forward to welcoming you in Brussels! But online participation will also be available to make sure everyone can take part in this renewed edition of our Annual Conference.
In partnership with
SIOP Europe and
ITCC, and supported by
The Andrew McDonough B+ Foundation, ACCELERATE provides a transparent forum enabling all stakeholders to collaborate and address specific obstacles to advance the development of more effective treatments for children and adolescents with cancer. The ACCELERATE Annual Conference is the perfect space to:
Learn about the most recent successes in paediatric oncology drug development worldwide, and the latest regulatory updates.
Discuss in breakout sessions how to accelerate the implementation of new oncology drug development for children in this new global landscape.
Discover the latest updates of the ACCELERATE programme, including Paediatric Strategy Forums, Working Groups, education initiatives, and much more!
Engage with our unique, multi-stakeholder network of clinicians and researchers, patients, survivors and advocates, regulators and industry representatives.